Northwest Biotherapeutics (NWBO) Shares Outstanding (2010 - 2026)

Northwest Biotherapeutics' Shares Outstanding (Entity) history runs 10 years deep, the most recent figure standing at $1.5 million for Q3 2025.

• On a quarterly basis, Shares Outstanding (Entity) changed N/A year-over-year to $1.5 million in Q3 2025; TTM through Sep 2025 was $1.5 million, a N/A change from a year earlier, with the FY2024 full-year figure at $1.2 million, changed N/A from the prior year.
• Shares Outstanding (Entity) climbed to $1.5 million in Q3 2025 per NWBO's latest filing, from $1.4 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $1.5 million in Q3 2025 and bottomed at $834605.0 in Q1 2021.
• The 4-year median for Shares Outstanding (Entity) is $1.1 million (2022), against an average of $1.1 million.
• Biggest YoY gain for Shares Outstanding (Entity) was 30.33% in 2021; the steepest drop was 17.15% in 2021.
• Year by year, Shares Outstanding (Entity) stood at $875963.0 in 2021, then climbed by 18.84% to $1.0 million in 2022, then gained by 19.33% to $1.2 million in 2024, then climbed by 20.11% to $1.5 million in 2025.
• Per Business Quant, the three latest NWBO Shares Outstanding (Entity) figures stand at $1.5 million (Q3 2025), $1.4 million (Q2 2025), and $1.4 million (Q1 2025).